Patent ID: 7989485

Claim:
A compound of formula I wherein R 1 represents H, F, Cl, Br, I, OH, CF 3 , methyl or ethyl; R 2 represents H, F, Cl, Br, I, OH, CF 3 , methyl or ethyl; R 3 represents tert-butyl, an unsubstituted cyclohexyl, a mono- or di-substituted phenyl with substituents independently selected from the group consisting of F, Cl, Br, I, and OH; or an unsubstituted naphthyl group; R 4 represents H; R 5 and R 6 , identical or different, represent a hydrogen atom; an unbranched or branched, optionally substituted C 1-6 alkyl group with substituents independently selected from the group consisting of F, Cl, Br, I, NH 2 , SH, OH, and CF 3 ; a saturated cycloalkyl group which is optionally substituted with substituents independently selected from the group consisting of F, Cl, Br, I, NH 2 , SH, OH, and CF 3 ; a branched or unbranched alkyl-aryl group which is optionally substituted with substituents independently selected from the group consisting of F, Cl, Br, I, NH 2 , SH, OH, and CF 3 ; or form together with the bridging nitrogen atom a piperidine, morpholine, pyrrolidine, azepane or piperazine group which is optionally substituted with substituents independently selected from the group consisting of halogen, NH 2 , SH, OH, optionally substituted C 1-6 -Alkyl, optionally substituted O—C 1-6 -Alkyl, optionally substituted C(O)—C 1-6 -Alkyl, and optionally substituted C 3-6 -Cycloalkyl; preferably with substituents independently selected from the group consisting of methyl, ethyl, methoxy, ethoxy, C(O)—CH 3 , F, Cl, Br, I, NH 2 , SH, OH, CF 3 , and cyclohexyl; most preferably with substituents independently selected from the group consisting of C(O)—CH 3 , methyl, and cyclohexyl; X represents a C═O— group; Y represents a nitrogen atom, a sulfur atom, or an SO 2 group; m is selected from 0 and 1; n is selected from 0 and 1; p is selected from 1, 2, 3, and 4; optionally in form of one of the stereoisomers, preferably enantiomers or diastereomers, a racemate or in form of a mixture of at least two of the stereoisomers, preferably enantiomers and/or diastereomers, in any mixing ratio, or a pharmaceutically acceptable salt thereof.